Chikungunya IgG, Antibody, Serum
Use
This test aids in the diagnosis of recent Chikungunya virus infection by detecting IgG antibodies in patients who have traveled recently to endemic areas and present with compatible symptoms. Chikungunya virus is a single-stranded RNA alphavirus transmitted by Aedes mosquitoes, and it is associated with symptoms such as high fever, incapacitating joint pain, and rash. The test provides significant information for the healthcare provider to assess recent infection and provide appropriate care. Patients with suspected infection may also require concurrent testing for other co-circulating viruses like Dengue.
Special Instructions
Not provided.
Limitations
The test may yield false-negative results if the specimen is collected too soon following infection, as antibodies may not yet be detectable. Cross-reactivity with other alphaviruses is possible, and results should be considered in conjunction with clinical presentation and exposure history. There is no licensed vaccine for Chikungunya, and the disorder can present similarly to other infections like Dengue, requiring comprehensive evaluation.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 88630-9 - CHIKV IgG SerPl Ql IA
- 88630-9 - CHIKV IgG SerPl Ql IA
Result Turnaround Time
1-14 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.4 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
Gross hemolysis, gross lipemia, gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 30 days |
| Frozen | 30 days |